Agents for Hyperlipidemia

HPI JL is a 55-year-old man s/p Ml 3 years ago. He was placed on cholesterol-lowering therapy following his Ml. He currently takes simvastatin to control his cholesterol. He finds it difficult to Incorporate any physical activity in his daily routine and does not attempt to reduce his cholesterol/fat intake. His most recent lipid panel is total cholesterol 206 mg/dU triglyericides 180 m dL high density lipoprotein 35 mg/dU low density lipoprotein 135 mg/dL. 

Would you modify his current lipid-lowering therapy If so, how  

What are the common side effects associated with lipidlowering medications  

Coronary heart disease (CHD) is one of the leading causes of morbidity and mortality in the United States. Hyperlipidemia is a major risk factor for atherosclerosis and CHD. Hyperlipidemia is defined as an elevation in blood cholesterol or triglycerides (TG). Lipids are primarily transported in the body by three major lipoproteins low-density (LDL), very-low-density (VLDL), and high-density lipoproteins (HDL). Cholesteryl esters and TG are carried by the lipoproteins, which vary in size and composition of cholesterol and 

---